Clinical Trial Update: A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag [Phase 4]

View source ↗

Summary

This is a Phase 4 prospective study evaluating lusutrombopag for aplastic anemia, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• lusutrombopag (lusutrombopag)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia | Phase 4 | Status: NOT_YET_RECRUITING